Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor cell lysis via viral infection refers to the process by which viruses, particularly oncolytic viruses (OVs), selectively infect and destroy cancer cells. This approach exploits the unique vulnerabilities of tumor cells to viral replication, leading to direct cell death (oncolysis) and stimulation of antitumor immune responses.
Direct lysis of tumor cells by viral replication; induction of antitumor immune response.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Cell Lysis via Viral Infection (Oncolysis).